| 000 | 01703 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250517140845.0 | ||
| 264 | 0 | _c20170918 | |
| 008 | 201709s 0 0 eng d | ||
| 022 | _a1949-2553 | ||
| 024 | 7 |
_a10.18632/oncotarget.15328 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aVannini, Eleonora | |
| 245 | 0 | 0 |
_aProgression of motor deficits in glioma-bearing mice: impact of CNF1 therapy at symptomatic stages. _h[electronic resource] |
| 260 |
_bOncotarget _cApr 2017 |
||
| 300 |
_a23539-23550 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 | _aAnalysis of Variance |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBacterial Toxins _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBrain _xdrug effects |
| 650 | 0 | 4 |
_aBrain Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 | _aDisease Models, Animal |
| 650 | 0 | 4 | _aDisease Progression |
| 650 | 0 | 4 | _aDisks Large Homolog 4 Protein |
| 650 | 0 | 4 |
_aEscherichia coli Proteins _xpharmacology |
| 650 | 0 | 4 |
_aGlioma _xdrug therapy |
| 650 | 0 | 4 |
_aGuanylate Kinases _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMembrane Proteins _xmetabolism |
| 650 | 0 | 4 | _aMice, Inbred C57BL |
| 650 | 0 | 4 |
_aMotor Activity _xdrug effects |
| 650 | 0 | 4 |
_aMotor Disorders _xdrug therapy |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 |
_aTumor Burden _xdrug effects |
| 700 | 1 | _aMaltese, Federica | |
| 700 | 1 | _aOlimpico, Francesco | |
| 700 | 1 | _aFabbri, Alessia | |
| 700 | 1 | _aCosta, Mario | |
| 700 | 1 | _aCaleo, Matteo | |
| 700 | 1 | _aBaroncelli, Laura | |
| 773 | 0 |
_tOncotarget _gvol. 8 _gno. 14 _gp. 23539-23550 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.18632/oncotarget.15328 _zAvailable from publisher's website |
| 999 |
_c26891532 _d26891532 |
||